Zollinger-ellison Syndrome
📧 Sign up to get email alerts when something new happens for Zollinger-ellison Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-09-21FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole). This action typically updates labeling, manu…
-
FDA approval · 2009-06-18FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP to update the la…
-
FDA approval · 2009-04-06FDA Approved: RANITIDINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for ranitidine submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2009-01-21FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for omeprazole filed by Quallent Pharmaceuticals Health LLC under an ANDA.
-
FDA approval · 2008-05-20FDA Approved: FAMOTIDINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for famotidine (Hikma Pharmaceuticals USA Inc.). The approval updates the labeling to reflect additi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-04-21FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID (lansoprazole) filed by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-21FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for PREVACID SOLUTAB (lansoprazole) filed by Takeda Pharmaceuticals America, expanding the product's…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Evaluating Patients With Abnormal Levels of Gastric Acid
The document reports the completion of an NIDDK clinical trial evaluating patients with abnormal gastric acid levels. It covers conditions s…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in patients with Zollinger-Ellison syndrome and pancreatic islet cell tumors has …
-
FDA approval · 2007-12-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals LLC, a subsidiary …
-
FDA approval · 2007-11-14FDA Approved: PROTONIX DELAYED-RELEASE — Original Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved the original application for Pantoprazole sodium delayed-release (Protonix Delayed-Release) by Wyeth/Pfizer for the treatment o…
-
FDA approval · 2007-10-22FDA Approved: OMEPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved the original (ANDA) application for omeprazole from Quallent Pharmaceuticals Health LLC, authorizing a generic omeprazole produ…
-
FDA approval · 2007-03-21FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole by Sandoz Inc. This action updates the current approval for this generic drug.
-
FDA approval · 2006-10-13FDA Approved: RANITIDINE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's original application for generic ranitidine, authorizing its commercial ranitidine…